Nicholas Turner
PhD, MBBS
Professor of Molecular Oncology
👥Biography 个人简介
Nicholas Turner at the Institute of Cancer Research and Royal Marsden is a leading translational researcher in HR-positive breast cancer. He has characterized mechanisms of CDK4/6 inhibitor resistance and pioneered ctDNA-based monitoring of ESR1 mutations during endocrine therapy. His PLAYTIME, CAPItello, and other trial contributions have defined optimal sequencing of CDK4/6 inhibitors and next-line endocrine strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nicholas Turner 的研究动态
Follow Nicholas Turner's research updates
留下邮箱，当我们发布与 Nicholas Turner（The Institute of Cancer Research / Royal Marsden Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment